1-7 of 7
ribociclib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drug Combinations Co-Targeting Myeloid Cell Leukemia-1 (Mcl-1) Protein Can Overcome Microenvironmentally-Induced Multi-Drug Tolerance in Non-Hodgkin Lymphomas

Kallesh D. Jayappa, DVM, PhD, Craig A. Portell, MD, Vicki L. Gordon, BSc, Goutham Narla, MD PhD, Timothy P. Bender, PhD, Michael E. Williams, MD, Michael J. Weber, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2649.
https://doi.org/10.1182/blood-2018-99-116759
Published: 2018
Journal Articles

The CDK4/6 Inhibitor Palbociclib Exerts Growth-Inhibitory Effects on Neoplastic Mast Cells and Synergizes with Midostaurin in Producing Growth Arrest

Mathias A. Schneeweiss, Gabriele Stefanzl, Daniela Berger, Gregor Eisenwort, Mohamad Jawhar, Greiner Georg, MD PhD, Gregor Hoermann, Wolfgang R. Sperr, Michel Arock, Andreas Reiter, MD, Peter Valent, Karoline V. Gleixner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1363.
https://doi.org/10.1182/blood-2018-99-116525
Published: 2018
Journal Articles

Synergistic Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Raajit K. Rampal, MD, PhD, Pinzon-Ortiz Maria, PhD, Hanasoge Somasundara Amritha Varshini, Ross L. Levine, MD, Alex Cao
Journal: Blood
Blood (2016) 128 (22): 634.
https://doi.org/10.1182/blood.V128.22.634.634
Published: 2016
Journal Articles

Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-Cell Acute Lymphoblastic Leukemia

Yana Pikman, MD, Andrew Furman, BA, Emily S. Lee, Andrew E. Place, MDPhD, Gabriela Alexe, PhD, Rebecca Modiste, RT(N), LAT, Prafulla Gokhale, PhD, Sunkyu Kim, PhD, Lewis B. Silverman, MD, Kimberly Stegmaier, MD
Journal: Blood
Blood (2015) 126 (23): 2488.
https://doi.org/10.1182/blood.V126.23.2488.2488
Published: 2015
Journal Articles

The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients

Frank Giles, MD MB, FRCPI, FRCPath, Sarina A. Piha-Paul, MD, Alexander I. Spira, PhD MD FACP, Fadi Braiteh, MD CPI, Julio Antonio Peguero, MD, Daniel L. Spitz, MD FACP, James A. Knost, MD, Lee Schwartzberg, MD FACP, Steven Stein, MD, August J. Salvado, MD, Claudia Lebedinsky, MD, Barinder Kang, PhD, Eric Slosberg, PhD
Journal: Blood
Blood (2014) 124 (21): 4818.
https://doi.org/10.1182/blood.V124.21.4818.4818
Published: 2014
Journal Articles

A Novel and Personalized Method Using Simulation for Predicting Effective Therapeutics for Waldenströms Macroglobulinemia

Abdel Kareem Azab, BPharm, PhD, Aneel Paulus, MDMS, Feda Azab, B.Pharm, Sharoon Akhtar, MPhil, Shireen Vali, PhD, Ansu Kumar, Neeraj Kumar Singh, Shweta Kapoor, Taher Abbasi, MS, Asher Chanan-Khan, MD, Kasyapa S. Chitta, PhD
Journal: Blood
Blood (2014) 124 (21): 3024.
https://doi.org/10.1182/blood.V124.21.3024.3024
Published: 2014
Journal Articles

Sensitizing shRNA Screen for Molecular Targets in CDK4/CDK6-Based Combination Therapy in Multiple Myeloma

Xiangao Huang, PhD, Maurizio Di Liberto, PhD, David Chiron, PhD, Ruben Niesvizky, MD, Anna C. Schinzel, PhD, William C. Hahn, MD PhD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2014) 124 (21): 3440.
https://doi.org/10.1182/blood.V124.21.3440.3440
Published: 2014